TARA study: a new perspective on tapering drugs in RA
- PMID: 31072817
- DOI: 10.1136/annrheumdis-2019-215594
TARA study: a new perspective on tapering drugs in RA
Keywords: DMARDs (biologic); DMARDs (synthetic); anti-TNF; methotrexate; rheumatoid arthritis.
Conflict of interest statement
Competing interests: None declared.
Comment in
-
Response to: 'TARA Study: a new perspective on tapering drugs in RA' by Mishra et al.Ann Rheum Dis. 2020 Jul;79(7):e80. doi: 10.1136/annrheumdis-2019-215641. Epub 2019 May 20. Ann Rheum Dis. 2020. PMID: 31110029 Free PMC article. No abstract available.
Comment on
-
Gradual tapering TNF inhibitors versus conventional synthetic DMARDs after achieving controlled disease in patients with rheumatoid arthritis: first-year results of the randomised controlled TARA study.Ann Rheum Dis. 2019 Jun;78(6):746-753. doi: 10.1136/annrheumdis-2018-214970. Epub 2019 Apr 6. Ann Rheum Dis. 2019. PMID: 30954969 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
